EARLY PSA RESPONSE IS AN INDEPENDENT PROGNOSTIC FACTOR IN PATIENTS WITH MCRPC TREATED WITH NEXT-GENERATION ANDROGEN PATHWAY INHIBITORS

被引:1
|
作者
Fuerea, A. C. [1 ]
Baciarello, G. [1 ]
Massard, C. [2 ]
Sauvin, L. Albiges [3 ]
Gizzi, M. [1 ]
Terrisse, S. A. [4 ]
Di Palma, M. [1 ]
Escudier, B. [5 ]
Fizazi, K. [6 ]
Loriot, Y. [5 ]
机构
[1] Inst Gustave Roussy, Villejuif, France
[2] Inst Gustave Roussy, SITEP, Villejuif, France
[3] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[4] Inst Canc Res, Dept Med Oncol, Villejuif, France
[5] Inst Cancerol Gustave Roussy, Villejuif, France
[6] Inst Gustave Roussy, Dept Canc Med, Villejuif, France
关键词
D O I
10.1093/annonc/mdu336.44
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
796P
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Early PSA response is an independent prognostic factor in patients with metastatic castration-resistant prostate cancer treated with next-generation androgen pathway inhibitors
    Fuerea, Alina
    Baciarello, Giulia
    Patrikidou, Anna
    Albiges, Laurence
    Massard, Christophe
    Di Palma, Mario
    Escudier, Bernard
    Fizazi, Karim
    Loriot, Yohann
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : 44 - 51
  • [2] Very Early PSA Response to Abiraterone in mCRPC Patients: A Novel Prognostic Factor Predicting Overall Survival
    Facchini, Gaetano
    Caffo, Orazio
    Ortega, Cinzia
    D'Aniello, Carmine
    Di Napoli, Marilena
    Cecere, Sabrina C.
    Della Pepa, Chiara
    Crispo, Anna
    Mines, Francesca
    Ruatta, Fiorella
    Iovane, Gelsomina
    Pisconti, Salvatore
    Montella, Maurizio
    Berretta, Massimiliano
    Pignata, Sandro
    Cavaliere, Carla
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [3] Early assessment of PSA response in patients with mCRPC treated with enzalutamide and abiraterone.
    Feibus, Allison H.
    Guccione, Jeffrey R.
    Vasudevamurthy, Ashwin
    Ledet, Elisa M.
    Cotogno, Patrick
    Manogue, Charlotte
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [4] Very early PSA response to abiraterone in mCRPC patients: A novel prognostic factor to predict overall survival.
    Cavaliere, Carla
    Caffo, Orazio
    Ortega, Cinzia
    D'aniello, Carmine
    Cecere, Sabrina Chiara
    Di Napoli, Marilena
    Della Pepa, Chiara
    Crispo, Anna
    Maines, Francesca
    Ruatta, Fiorella
    Iovane, Gelsomina
    Montella, Maurizio
    Pignata, Sandro
    Facchini, Gaetano
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [5] Next-Generation Androgen Receptor-Signaling Inhibitors for Prostate Cancer: Considerations for Older Patients
    Feng, Zizhen
    Graff, Julie N.
    DRUGS & AGING, 2021, 38 (02) : 111 - 123
  • [6] Next-Generation Androgen Receptor-Signaling Inhibitors for Prostate Cancer: Considerations for Older Patients
    Zizhen Feng
    Julie N. Graff
    Drugs & Aging, 2021, 38 : 111 - 123
  • [7] Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated with radiotherapy combined or not with androgen deprivation therapy
    Heyns, C. F.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 903 - U239
  • [8] Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
    de Crevoisier, R.
    Slimane, K.
    Messai, T.
    Wibault, P.
    Eschwege, F.
    Bossi, A.
    Koscielny, S.
    Bridier, A.
    Massard, C.
    Fizazi, K.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 808 - 814
  • [9] Early undetectable serum PSA is an independent predictive factor of progression-free survival (PFS) in patients with localized prostate cancer treated by androgen deprivation and radiotherapy
    Slimane, Khemaies
    De Crevoisier, Renaud
    Wibault, Pierre
    Eschwege, Francois
    Fizazi, Karim
    ANNALS OF ONCOLOGY, 2004, 15 : 115 - 115
  • [10] Prognostic Impact of Molecular Response Assessed By Next-Generation Sequencing in a Large Cohort of Multiple Myeloma Patients
    Sanchez-Vega, Beatriz
    Alonso, Rafael
    Cuenca, Isabel
    Barrio, Santiago
    Ruiz-Heredia, Yanira
    Marin, Carlos
    Rapado, Inmaculada
    Jimenez, Cristina
    Aguirre, Xabier
    Ayala, Rosa M.
    Cedena, Teresa
    Paiva, Bruno
    Mateos, Maria-Victoria
    Rosinol, Laura
    Blade, Joan
    San Miguel, Jesus
    Garcia-Sanz, Ramon
    Lahuerta, Juan Jose
    Martinez-Lopez, Joaquin
    BLOOD, 2016, 128 (22)